Andere talen Athersys, Inc.

Aandelen

ATHXQ

US04744L2051

Beurs gesloten - OTC Markets Andere beurzen 21:42:02 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0044 ^USD	0,00%		-2,22%	-78,00%

05/04	Athersys, Inc. Kondigt bestuurswijzigingen aan	CI
03/04	Healios K.K. (TSE:4593) heeft de overname afgerond van vrijwel alle activa van Abt Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA en ReGenesys, LLC .	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	11/04
Athersys : Acquisition/Asset Disposal - Form 8-K	05/04
Athersys, Inc. Announces Board Changes	05/04
Healios Concludes Purchase of Athersys Assets, Becoming Sole Owner of MultiStem IP	04/04
North American Morning Briefing : Focus Turns to -2-	04/04
Healios K.K. completed the acquisition of Substantially all assets of Abt Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC .	03/04
Final DIP Financing Approved for Athersys, Inc.	13/02
Bidding Procedure Approved for Athersys, Inc.	13/02
Healios' Ischemic Stroke Trial Data Published in JAMA Neurology Journal	18/01
Interim DIP Financing Approved for Athersys, Inc.	12/01
Motion for Joint Administration Approved for Athersys, Inc.	12/01
Healios Steps In as Primary Bidder and Lender for Athersys’s Asset Sale Amidst Bankruptcy	10/01
Motion for Asset Sale Filed by Athersys, Inc.	06/01
Motion for Joint Administration Filed by Athersys, Inc.	06/01
Athersys, Inc. Filed for Bankruptcy	05/01
Healios K.K. entered into an asset purchase agreement to acquire Substantially all assets of ABT Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC for $2.8 million.	05/01
Athersys, Inc. Announces Termination of Maia Hansen as Chief Operating Officer, Effective from December 31, 2023	22/12
Athersys, Inc. Announces Termination of Daniel A. Camardo as Chief Executive Officer, Effective from December 31, 2023	22/12
Athersys Reports Third Quarter 2023 Financial Results and Business Highlights	17/11
Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives	17/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Athersys, Inc.

Aandelen

ATHXQ

US04744L2051

Andere talen

Filters